Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

27.20
-0.2300-0.84%
Post-market: 27.200.00000.00%16:52 EDT
Volume:2.62M
Turnover:70.50M
Market Cap:3.43B
PE:-19.01
High:27.53
Open:27.01
Low:26.04
Close:27.43
52wk High:41.14
52wk Low:10.83
Shares:126.00M
Float Shares:110.00M
Volume Ratio:2.00
T/O Rate:2.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:14.33
PE(LYR):-17.77

Loading ...

OverviewCompanyNewsFilings

Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Aug 19

Amylyx Pharmaceuticals, - Proceeds to Fund Avexitide Pre-Commercial Activities, R&D, and General Corporate Purposes

THOMSON REUTERS
·
Aug 19

Amylyx Pharmaceuticals Price Target Raised to $55.00/Share from $34.00 by HC Wainwright & Co.

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Gold Miners, Weave Communications, Amylyx Pharmaceuticals

Reuters
·
Aug 19

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 19

Amylyx price target raised to $55 from $34 at H.C. Wainwright

TIPRANKS
·
Aug 19

Amylyx Pharmaceuticals up over 50%, on Pace for Largest Percent Increase Since September 2022

Dow Jones
·
Aug 18

Under the Radar: Amylyx Stock Surges on Positive Trial Results

Dow Jones
·
Aug 18

Top Midday Stories: Home Depot Q2 EPS, Revenue Top Estimates; Klarna Cuts Guidance, Plans CFO, CMO Transitions

MT Newswires Live
·
Aug 18

Shares of Amylyx Pharmaceuticals Surge Nearly 51% as Key Trial Meets Main Goal

Stock News
·
Aug 18

Amylyx Soars as Blood Sugar Drug Succeeds in Late-Stage Trial

Reuters
·
Aug 18

Amylyx Shares Jump 45% Following Positive Phase 3 Trial Results for GLP-1 Blocker Avexitide

TIPRANKS
·
Aug 18

Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), Insight Molecular Diagnostics (IMDX) and Innovent Biologics (OtherIVBXF)

TIPRANKS
·
Aug 18

Stifel views Amylyx data as ‘best-case scenario’

TIPRANKS
·
Aug 18

Amylyx Phase 3 data support FDA approval, says Citi

TIPRANKS
·
Aug 18

Amylyx rises 41.7%

TIPRANKS
·
Aug 18

Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday

MT Newswires Live
·
Aug 18

Amylyx up 28% at $27.50 after announcing Lucidity trial met primary endpoint

TIPRANKS
·
Aug 18

Amylyx Shares up 29.7% Premarket After Co Says Its Drug Cuts Low Blood Sugar Episodes in Bariatric Surgery Patients in Key Trial

THOMSON REUTERS
·
Aug 18

Amylyx Stock Surges 42% After GLP-1 Drug Succeeds in Phase 3 Trial

Dow Jones
·
Aug 18
More